0.78 USD
↘ 0.00 (0.36%)LIVE (AS OF 02:45 PM EDT)
EVOGENE LTD.
EVGNNASDAQ • USD
Market: OPEN
Open?$0.78
High?$0.83
Low?$0.78
Prev. Close?$0.78
Volume?82.0K
Avg. Volume?148.0K
VWAP?$0.81
Rel. Volume?0.55x
Bid / Ask
Bid?$0.67 × 100
Ask?$0.93 × 100
Spread?$0.26
Midpoint?$0.80
Valuation & Ratios
Market Cap?7.7M
Shares Out?N/A
Float?8.6M
Float %?99.0%
P/E Ratio?N/A
P/B Ratio?0.08
EPS?-$1.74
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?17.67Strong
Quick Ratio?17.67Strong
Cash Ratio?0.87Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?0.08CHEAP▾
P/S?0.74CHEAP▾
P/FCF?N/A▾
EV/EBITDA?-0.2CHEAP▾
EV/Sales?0.36CHEAP▾
Returns & Efficiency
ROE?-17.0%WEAK▾
ROA?-15.8%WEAK▾
Cash Flow & Enterprise
FCF?$-13724000
Enterprise Value?$3.7M
Related Companies
Loading...
News
Profile
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.